Original language | English (US) |
---|---|
Pages (from-to) | 859-860 |
Number of pages | 2 |
Journal | Cancer |
Volume | 128 |
Issue number | S4 |
DOIs |
|
State | Published - Feb 15 2022 |
ASJC Scopus subject areas
- Oncology
- Cancer Research
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Cancer, Vol. 128, No. S4, 15.02.2022, p. 859-860.
Research output: Contribution to journal › Comment/debate › peer-review
}
TY - JOUR
T1 - Multicancer early detection
T2 - International summit to Clarify the Roadmap
AU - Limburg, Paul J.
AU - Ahlquist, David A.
AU - Johnson, Sonali
AU - Jayasekar Zurn, Shalini
AU - Kisiel, John B.
AU - Smith, Robert A.
N1 - Funding Information: Paul J. Limburg serves as chief medical officer for screening at Exact Sciences (Madison, Wisconsin), and he and the Mayo Clinic have rights to receive royalties through a contracted services agreement with Exact Sciences; he also reports medical writing support from Exact Sciences for other projects. David A. Ahlquist received support from a sponsored research agreement between the Mayo Clinic and Exact Sciences and was an inventor of Mayo Clinic intellectual property that has been licensed to Exact Sciences for which he received royalties (paid to the Mayo Clinic); he also had a consulting company, EDACA LLC, that was contracted by Exact Sciences, received travel support from Exact Sciences, participated in scientific advisory board meetings for Exact Sciences, and received stock from Exact Sciences. Sonali Johnson reports travel support for the Universal Cancer Screening Summit from the Mayo Clinic (February 3‐4, 2020). John B. Kisiel and the Mayo Clinic have rights to receive royalties paid to the Mayo Clinic through a contracted services agreement with Exact Sciences; he also has served on 4 scientific advisory boards for Exact Sciences. Robert A. Smith is employed by the American Cancer Society, which receives grants from private and corporate foundations, including foundations associated with companies in the health sector, outside the submitted work; his salary is funded solely through American Cancer Society funds. The other author made no disclosures.
PY - 2022/2/15
Y1 - 2022/2/15
UR - http://www.scopus.com/inward/record.url?scp=85124325697&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85124325697&partnerID=8YFLogxK
U2 - 10.1002/cncr.33964
DO - 10.1002/cncr.33964
M3 - Comment/debate
C2 - 35133657
AN - SCOPUS:85124325697
SN - 0008-543X
VL - 128
SP - 859
EP - 860
JO - Cancer
JF - Cancer
IS - S4
ER -